Top 10 Companies in the (S)-Trifluoroisopropylamine Hydrochloride (CAS 125353-44-8) Market (2026): Market Leaders Powering Global Fluorinated Chemistry

MARKET INSIGHTS

Global (S)-Trifluoroisopropylamine hydrochloride (CAS 125353-44-8) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 7.3% during the forecast period.

(S)-Trifluoroisopropylamine hydrochloride is a chiral fluorinated building block widely utilized in pharmaceutical synthesis and agrochemical development. Its defining structural feature – a trifluoromethyl group attached to an optically active amine center – imparts unique metabolic stability, enhanced lipophilicity, and improved bioavailability to drug candidates, making it a highly valued intermediate in medicinal chemistry workflows.

The market is gaining steady momentum, primarily driven by the growing global demand for fluorinated pharmaceutical intermediates and the expanding pipeline of small‑molecule drug candidates incorporating chiral trifluoromethyl moieties. Furthermore, rising investments in asymmetric synthesis and enantioselective catalysis are broadening the compound’s application scope. Key suppliers operating in this space include Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Fluorochem, among other specialty fine chemical manufacturers.

(S)-Trifluoroisopropylamine hydrochloride (CAS 125353-44-8) Market – View in Detailed Research Report

TOP 10 COMPANIES

🔟 1. Fluorochem Ltd.

Headquarters: United Kingdom
Key Offering: High‑purity (≥99%) (S)-Trifluoroisopropylamine hydrochloride, custom synthesis, and technical support for asymmetric catalysis.

Fluorochem has pioneered fluorination technologies that enable scalable, enantioselective synthesis of (S)-Trifluoroisopropylamine hydrochloride with consistent >99% enantiomeric excess. Their process leverages proprietary chiral catalysts and flow‑chemistry platforms to deliver high purity intermediates to pharmaceutical and agrochemical developers.

Sustainability & Growth Initiatives:

• Investments in green fluorination processes reducing hazardous waste.
• Expansion of contract manufacturing services for API development.
• Collaborations with leading pharma companies to integrate fluorinated building blocks into CNS‑active drug discovery.

9️⃣ 2. Combi‑Blocks Inc.

Headquarters: United States
Key Offering: Research‑grade and intermediate‑grade (S)-Trifluoroisopropylamine hydrochloride, rapid custom synthesis.

Combi‑Blocks specializes in providing flexible, small‑batch supply of chiral fluorinated amines to academic and biotech laboratories. Their state‑of‑the‑art synthesis platform delivers high purity intermediates with rapid turnaround times.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recycling.
• Partnerships with CROs to support early‑stage discovery.
• Development of analytical kits for rapid ee verification.

8️⃣ 3. Shanghai Holdenchem Co., Ltd.

Headquarters: China
Key Offering: Pharmaceutical‑grade (S)-Trifluoroisopropylamine hydrochloride, large‑scale production.

Shanghai Holdenchem leverages advanced chiral resolution and catalytic reduction techniques to produce kilogram‑scale batches with >99% enantiomeric purity, serving major pharma and CDMO customers in Asia.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in manufacturing facilities.
• Expansion of local supply chain to reduce import dependency.
• R&D investment in biocatalytic synthesis routes.

7️⃣ 4. Nanjing Chemlin Chemical Industry Co., Ltd.

Headquarters: China
Key Offering: Custom synthesis and small‑batch supply for research labs.

Chemlin focuses on delivering high‑quality chiral intermediates with flexible specifications, enabling academic and industrial partners to integrate fluorinated building blocks into diverse synthetic routes.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management.
• Collaborations with universities for advanced asymmetric catalysis research.
• Digital platform for real‑time order tracking.

6️⃣ 5. Wuhan Fortuna Chemical Co., Ltd.

Headquarters: China
Key Offering: Research‑grade (S)-Trifluoroisopropylamine hydrochloride, rapid custom synthesis.

Fortuna provides cost‑effective, high‑purity intermediates with quick turnaround, supporting CROs and early‑stage drug discovery programs.

Sustainability & Growth Initiatives:

• Investment in waste‑minimization technologies.
• Expansion of product portfolio to include other chiral fluorinated amines.
• Strategic alliances with global CDMOs.

5️⃣ 6. ABCR GmbH

Headquarters: Germany
Key Offering: Pharmaceutical‑grade (S)-Trifluoroisopropylamine hydrochloride, custom synthesis.

ABCR supplies high‑purity intermediates with rigorous analytical support, catering to European pharma and biotech companies requiring stringent regulatory compliance.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles in synthesis.
• Partnerships with EU research consortia on fluorine chemistry.
• Continuous improvement of process safety protocols.

4️⃣ 7. Hangzhou Zhongchang Chemical Technology Co., Ltd.

Headquarters: China
Key Offering: Research‑grade and custom synthesis of (S)-Trifluoroisopropylamine hydrochloride.

Hangzhou Zhongchang delivers flexible, high‑purity intermediates with an emphasis on rapid response times for academic and industrial clients.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes.
• Expansion of digital procurement platform.
• Collaboration with academic institutions on asymmetric catalysis.

3️⃣ 8. Sigma‑Aldrich (Merck KGaA)

Headquarters: Germany
Key Offering: Comprehensive catalog of high‑purity (S)-Trifluoroisopropylamine hydrochloride, technical support, and supply chain solutions.

Sigma‑Aldrich is a global leader in fine chemicals, providing reliable, GMP‑compliant intermediates to pharmaceutical and agrochemical sectors worldwide.

Sustainability & Growth Initiatives:

• Investment in renewable energy for manufacturing sites.
• Development of eco‑friendly fluorination reagents.
• Strategic partnerships with leading pharma companies.

2️⃣ 9. TCI Chemicals

Headquarters: Japan
Key Offering: High‑purity (S)-Trifluoroisopropylamine hydrochloride, custom synthesis, and analytical services.

TCI provides high‑quality intermediates with robust analytical support, serving the pharmaceutical, agrochemical, and specialty chemical markets.

Sustainability & Growth Initiatives:

• Implementation of waste‑reduction programs.
• Expansion of digital order management system.
• Collaboration with research institutions on fluorinated chemistry.

1️⃣ 10. Sinochem Lantian

Headquarters: China
Key Offering: Large‑scale production of (S)-Trifluoroisopropylamine hydrochloride, custom synthesis, and supply chain solutions.

Sinochem Lantian supplies high‑purity intermediates to global pharma and CDMO customers, leveraging advanced chiral resolution and catalytic technologies.

Sustainability & Growth Initiatives:

• Adoption of green fluorination processes.
• Expansion of domestic manufacturing capacity.
• Strategic alliances with international pharma companies.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307932/trifluoroisopropylamine-hydrochloride-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307932/trifluoroisopropylamine-hydrochloride-market

🌍 Outlook: The Future of (S)-Trifluoroisopropylamine Hydrochloride Market

The global demand for fluorinated intermediates is expected to accelerate, driven by the expanding pipeline of CNS‑active, oncology, and metabolic disease therapeutics. The increasing adoption of asymmetric catalysis and biocatalytic synthesis methods will further enhance the supply chain resilience and reduce production costs for high‑purity intermediates. Geographic diversification, especially in Asia‑Pacific and emerging markets, will broaden the customer base and create new opportunities for specialty chemical suppliers.

📈 Key Trends Shaping the Market:

• Rapid growth of contract research and manufacturing organizations (CROs/CDMOs) in Asia‑Pacific.
• Advancements in flow‑chemistry and continuous‑flow fluorination platforms.
• Increased regulatory emphasis on enantiomeric purity and GMP compliance.
• Expansion of fluorinated chiral building blocks into agrochemical and material science applications.
• Digitalization of supply chain and procurement platforms for faster, more transparent ordering.